Among women in the general US population, simultaneous screening with CA-125 and transvaginal ultrasound compared with usual care did not reduce ovarian cancer mortality. Diagnostic evaluation following a false-positive screening test result was associated with complications. Trial Registration clinicaltrials.gov Identifier: NCT00002540.
No takes yet. Share an insight, caveat, or question.
Saundra S. Buys (2011) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: